BioPharma
Harbour BioMed Partners With Lannacheng To Advance Next Generation Radionuclide Drug Conjugates
Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunolo...
January 02, 2026 | News
2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
At the centre of this momentum stood the U.S. Food and Drug Administration, whose 2025 approvals illustrated how medicine is moving decisiv...
December 29, 2025 | Analysis | By arcilla.fran@biopharmaapac.com
BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
The year 2025 has marked a pivotal moment for the biopharmaceutical industry as it reckons with the aftershocks of a global pandemic and ongoing geopolitic...
December 24, 2025 | Analysis
CHITOSE And FUJIFILM Biosciences Form Strategic Alliance To Advance Biopharmaceutical Manufacturing
Collaboration formed to accelerate biopharmaceutical manufacturing combining high performing CHO-MK cells and GMP-manufactured culture media. Ch...
December 22, 2025 | News
Thermo Fisher Scientific Advances Microbial Bioprocessing With Chemically Defined Media For Confident Plasmid DNA And Protein Scale Up
New formulations simplify microbial bioprocessing, helping innovators scale plasmid DNA and protein production with confidence Thermo Fisher Scientific In...
December 16, 2025 | News
APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
APAC Biopharma in Review: What Truly Moved the Needle This Year Asia-Pacific (APAC) has cemented its status as a pivotal biopharmaceutical hub in 2025, ma...
December 15, 2025 | Report
Thermo Fisher Expands Bioprocess Network Across Asia to Strengthen Regional Biomanufacturing Capabilities
New and expanded facilities provide local expertise, advanced technologies and tailored support for biopharma innovators throughout the region Thermo Fish...
December 03, 2025 | News
Imugene and JW Therapeutics Launch First-in-Class “Mark and Kill” Solid Tumor Collaboration
Imugene and JW Therapeutics (Shanghai) Co., LTD have entered a strategic collaboration to evaluate a novel combination therapy using Imugene's onCARlytic...
December 01, 2025 | News
Vaxcellbio’s CSO Outlines How DDS Enabled Nanobodies Could Redefine Global Treatment Pathways
Vaxcellbio is betting on the combined power of nanobodies and advanced drug delivery science to push boundaries across ophthalmology and other chronic dise...
November 20, 2025 | Interaction
Thermo Fisher Opens Advanced Therapies Collaboration Center In Philadelphia To Accelerate Cell And Gene Therapy Development
New state-of-the-art facility in Philadelphia provides integrated lab and collaboration space along with tailored guidance to help move advanced therapies ...
November 19, 2025 | News
Evonik and InVitria Partner to Expand Global Supply of Animal Component-Free Recombinant HSA
Expanded supply of animal component-free human serum albumin for advanced therapies and next-generation biopharmaceutical processes Safer, more consiste...
November 18, 2025 | News
Insilico Medicine and Eli Lilly Expand Collaboration to Accelerate AI-Driven Drug Discovery
Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced a research collabor...
November 11, 2025 | News
Peli BioThermal Expands Allentown Service Center to Strengthen Global Pharmaceutical Cold Chain Network
Peli BioThermal, the global leader in temperature-controlled packaging solutions, announced that its newly expanded Allentown, Pennsylvania Service Cente...
November 04, 2025 | News
MilliporeSigma and Promega Forge Strategic Partnership to Advance Next-Generation Drug Discovery
Partnership combines MilliporeSigma’s chemistry and organoid expertise with Promega’s assay technologies. Aims to improve researcher acces...
November 04, 2025 | News
Most Read
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
